Nicholas B. Hawkins Sells 4,560 Shares of Arteris, Inc. (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIPGet Free Report) CFO Nicholas B. Hawkins sold 4,560 shares of the business’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $12.34, for a total transaction of $56,270.40. Following the transaction, the chief financial officer now directly owns 165,308 shares of the company’s stock, valued at $2,039,900.72. The trade was a 2.68 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Arteris Stock Performance

AIP stock opened at $11.25 on Friday. The company has a 50-day simple moving average of $9.25 and a 200 day simple moving average of $8.15. The company has a market capitalization of $451.99 million, a P/E ratio of -11.72 and a beta of 1.17. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30. Arteris, Inc. has a fifty-two week low of $4.83 and a fifty-two week high of $12.64.

Institutional Trading of Arteris

A number of hedge funds and other institutional investors have recently made changes to their positions in AIP. US Bancorp DE bought a new position in shares of Arteris in the third quarter valued at approximately $34,000. The Manufacturers Life Insurance Company bought a new position in Arteris during the 2nd quarter valued at $86,000. Algert Global LLC acquired a new position in shares of Arteris during the 2nd quarter valued at $115,000. MetLife Investment Management LLC raised its stake in shares of Arteris by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock worth $131,000 after buying an additional 9,551 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in shares of Arteris in the third quarter valued at $226,000. 64.36% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Separately, Rosenblatt Securities reiterated a “buy” rating and set a $15.00 price objective on shares of Arteris in a research report on Wednesday, November 6th.

View Our Latest Stock Report on Arteris

About Arteris

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Featured Stories

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.